Park Place Capital’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
ACH
NAMA
Park Place Capital's VCYT Position: Q3 2024 in Review
Park Place Capital sold out of Veracyte (VCYT) in Q3 2024, closing a stake of 24 shares — an estimated $520 sold.
Park Place Capital first reported a position in VCYT in Q4 2022 and held it in 7 quarters. The position peaked at $4.03K in Q1 2024. 293 funds tracked by Wall St. Rank hold VCYT as of Q3 2024.
- Park Place Capital reported no remaining Veracyte position as of Q3 2024 after selling out during the quarter.
- Park Place Capital sold 24 Veracyte shares in Q3 2024, an estimated $520.
- Park Place Capital first reported a position in Veracyte in Q4 2022 and held it in 7 quarters.
- Park Place Capital's Veracyte position peaked at $4.03K in Q1 2024.
- 293 funds tracked by Wall St. Rank held Veracyte as of Q3 2024.
Based on Park Place Capital's 13F filing for Q3 2024, filed 8 Oct 2024.